Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06354712

Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.

Clinical Study Evaluating the Efficacy and Safety of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.

Sponsor: Mansoura University

Conditions Oral Mucositis (Ulcerative) Due to Radiation

Interventions Institutional standard care N-Acetyl-Cysteine with Institutional standard care

Updated 5 times since 2024 Last updated: Jan 14, 2025 Started: Apr 4, 2024 Primary completion: Mar 1, 2025 Completion: Mar 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Oral Mucositis (Ulcerative) Due to Radiation, this trial is actively recruiting participants. The trial is conducted by Mansoura University and has accumulated 5 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Recruiting PHASE2
Feb 2025 — Sep 2025 [monthly]

Recruiting PHASE2
Sep 2024 — Feb 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
May 2024 — Jul 2024 [monthly]

Recruiting PHASE2

First recorded

Apr 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mansoura University

Data source: Mansoura University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Al Mansurah, Egypt